Cliff Asness’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$542K Buy
+11,830
New +$645K ﹤0.01% 3392
2023
Q4
– Sell
-12,972
Closed -$177K – 2356
2023
Q3
$177K Buy
+12,972
New +$218K ﹤0.01% 2157

Other funds holding ELVN

Cliff Asness's ELVN Position: Q3 2026 in Review

Cliff Asness opened a new position in Enliven Therapeutics (ELVN) in Q3 2026: 11,830 shares worth $542K. The stake represents ﹤0.01% of the portfolio and ranks #3392 among its holdings. This is a return to the name: Cliff Asness previously reported a position in ELVN as recently as Q3 2023.

Cliff Asness first reported a position in ELVN in Q3 2023 and has held it in 2 quarters since. 216 funds tracked by Wall St. Rank hold ELVN as of Q3 2026.

  • Cliff Asness held 11,830 shares of Enliven Therapeutics worth $542K as of Q3 2026.
  • Enliven Therapeutics was a new Cliff Asness position in Q3 2026.
  • Enliven Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3392 holding.
  • Cliff Asness first reported a position in Enliven Therapeutics in Q3 2023 and has held it in 2 quarters since.
  • 216 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.